MARTY JOHN MUSNI: Open Payments
NPI 1013795038 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 39 payments from 18 companies in 2025. Trend: 2023 $23 · 2024 $456 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $213 |
| AstraZeneca Pharmaceuticals LP | 7 | $147 |
| Otsuka America Pharmaceutical, Inc. | 3 | $80 |
| Seqirus USA Inc | 3 | $72 |
| Amgen Inc. | 3 | $62 |
| Medtronic, Inc. | 1 | $44 |
| PFIZER INC. | 2 | $44 |
| Lilly USA, LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| ABBVIE INC. | 1 | $34 |
Products named: Wegovy, REXULTI, Rybelsus, AIRSUPRA, Flucelvax, SYMPLICITY G3, PREVNAR 20, Ozempic.
Industry payments across CO — which companies pay providers there.
